Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate-Reference-Cited by-同舟云学术

Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate

Published:2020-10 Issue: Volume:153 Page:105485
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Castaman G.,Borchiellini A.,Santagostino E.,Radossi P.,Aksu S.,Yilmaz M.,Serban M.,Uscatescu V.,Truica C.,Fasulo M.R.,Mancuso M.E.,Paladino E.,Valpreda A.,Guarnieri C.,Macchia R.,Scarpellini M.,Mathew P.,Morfini M.^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference33 articles.

1. Pharmacokinetic study of a high-purity factor IX concentrate (Factor IX Grifols) with a 6-month follow up in previously treated patients with severe haemophilia B;Aznar;Haemophilia,2009

2. Human parvovirus B19 infection in haemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates;Azzi;Am. J. Hematol.,1992

3. TT virus contaminates first-generation recombinant factor VIII concentrates;Azzi;Blood,2001

4. Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation;Björkman;Eur. J. Clin. Pharmacol.,1994

5. In vivo recovery of factor VIII and factor IX: intra-and interindividual variance in a clinical setting;Björkman;Haemophilia,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic study of granisetron in human plasma measured by UPLC-MS/MS and its use in healthy Chinese subjects;PAK J PHARM SCI;2024

2. Determination of rebamipide in human plasma by a validated liquid chromatography-tandem mass spectrometry: Application in pharmacokinetics research;PAK J PHARM SCI;2023

3. Pharmacokinetic characteristics of the triple inactivated plasma-derived Kedrion FIX concentrate: data from the KB037 clinical trial;Data in Brief;2020-10